China Health Insurance: As Funding, Expenditure Grow, How Will Pharma Companies Make Out?
This article was originally published in PharmAsia News
Executive Summary
The outflow growth rate for China’s national insurance fund has increased faster than inflow since China implemented healthcare reforms, but the government managed to reverse the trend last year through cost-containment measures. PharmAsia News takes a closer look at how those actions might impact pharma companies.